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Abstract. Treponema denticola is a small anaerobic spirochete often isolated from periodontal lesions
and closely associated with periodontal diseases. This bacterium possesses a particular arginine peptidase
activity (previously called “BANA-peptidase” or “trypsin-like enzyme”) that is common to the three
cultivable bacterial species most highly associated with severe periodontal disease. We recently reported
the identification of theopdB locus that encodes the BANA-peptidase activity ofT. denticola through
DNA sequencing and mutagenesis studies. In the present study, we report expression ofT. denticola
OpdB peptidase inEscherichia coli. The opdB PCR product was cloned into pET30b and then
transformed into theE. coli BL21 (DE3)/pLysS expression strain. Assays of enzymatic activities inE.
coli containingT. denticola opdB showed BANA-peptidase activity similar to that ofT. denticola.
Availability of this recombinant expression system producing active peptidase will facilitate character-
ization of the potential role of this peptidase in periodontal disease etiology.
A specific complex of three cultivable anaerobic organ-
isms including Treponema denticola, Porphyromonas
gingivalis, and Bacteroides forsythus is associated with
periodontal disease severity [11]. These bacteria express
high levels of a particular peptidase activity previously
designated “BANA-peptidase” or “trypsin-like enzyme”
that is absent or expressed at low levels by other mi-
crobes [4]. Presence of one or more of these organisms in
subgingival plaque of periodontal lesions can be deter-
mined by the ability of the plaque to hydrolyzeN--
benzoyl-DL-arginine-2-naphthylamide (BANA) andN--
benzoyl-L-arginine-p-nitroanilide (BApNA) [5,6]. A
clinical diagnostic “BANA-test” kit has been developed
and tested in practice [5,6]. Even though the association
of periodontal disease severity with these specific organ-
isms and with high levels of BANA-hydrolyzing activity
is well established, no studies have been conducted to
investigate whether this enzyme activity itself has a
function in periodontal disease pathogenesis.
Treponema denticola is a cultivable anaerobic spi-
rochete often isolated from periodontal lesions. This
bacterium expresses several virulence behaviors, such as
adherence, cytotoxicity, iron sequestration, and locomo-
tion, which are likely to contribute to the periodontal
disease process [2]. A BANA-peptidase ofT. denticola
has been isolated, and its biochemical activity has been
characterized [8–10]. The activity profile of the outer
membrane-associated enzyme showed it to be an oli-
gopeptidase capable of hydrolyzing ester, amide, and
peptide bonds involving the carboxyl group arginine and
lysine and, combined with partial peptide sequences [7],
suggested that it belongs to the superfamily of prolyl
oligopeptidase that includesEscherichia coli oligopepti-
dase B (EC 3.4.21.83). Recently, theopdB locus that
encodes the BANA-peptidase activity ofT. denticola
was identified. In that study, an isogenicT. denticola
opdB mutant constructed by allelic replacement mu-
tagenesis demonstrated thatopdB encodes all trypsin-
like activity of T. denticola under in vitro conditions [3].
While the opdB gene and the native OpdB protein
have been characterized, expression of this gene inE.
coli has not been previously described. Availability of a
recombinant expression system for the BANA-peptidase
will facilitate further investigation of the potential role ofCorrespondence to: J.C. Fenno;email: fenno@umich.edu
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this enzyme in the pathogenesis of T. denticola. In this
study, we report recombinant expression of the T. den-
ticola BANA-peptidase in E. coli.
Materials and Methods
Bacteria and culture conditions. T. denticola ATCC 35405 was
grown in NOS broth as previously described [1]. Genomic DNA was
prepared from T. denticola by using a Wizard Genomic DNA purifi-
cation kit (Promega, Madison, WI, USA). E. coli JM109 and BL21
(DE3)/pLysS (Novagen, Inc., Madison, WI, USA) were used as hosts
for cloning and expression, respectively. E. coli was grown on LB agar
or broth medium with appropriate antibiotic selection.
Cloning into pET30b and expression. Oligonucleotide primers
CX230 (5 GGA GAA ATC ATA TGA AAC AAT CTG ATT CTG
AAA AGC CGC C 3) and CX232 (5 GAT TAA ATC AAG AAC
CCC GAC AAG CTT CGG GGT ACA GTG C 3) were used to
amplify a DNA fragment including opdB from T. denticola genomic
DNA. PCR amplification of DNA was performed on a programmable
thermal controller (PTC-100, MJ Research, Inc., Watertown, MA,
USA). The reaction mixture (100 L) contained 0.5 M of each primer,
0.2 mM each of the four deoxynucleoside triphosphates, 50 mM KCl, 20
mM Tris-HCl (pH 8.4), 2.5 mM MgCl2, and 2.5 U of Taq DNA
polymerase (Invitrogen, Carlsbad, CA, USA). The following reaction
conditions were used: annealing, 55°C for 30 s; extension, 72°C for 2
min; and denaturation, 95°C for 30 s. The cycles were repeated 30
times. PCR amplification products were cloned into TA cloning vector
pSTBlue-1 by using Acceptor Vector Kits (Novagen), yielding
pSY113. pSY113 was digested with NdeI and HindIII and cloned into
expression vector pET30b (Novagen), yielding pSY115 (Fig. 1). Ex-
pression of opdB cloned into pET30b was performed as described in
pET expression system manual book supplied by Novagen. Briefly,
pSY115 was transformed into E. coli BL21(DE3)/pLysS and plated
onto LB agar plate containing 30 g/mL of kanamycin and 34 g/mL
of chloramphenicol. A single transformed colony was inoculated into
LB broth containing 30 g/mL of kanamycin and 34 g/mL of chlor-
amphenicol, and grown at 37°C on a shaking incubator until OD600
reached 0.5. For inducing expression, isopropylthiogalactopyranoside
(IPTG; Sigma, St. Louis, MO, USA) was added to a final concentration
of 1 mM. After incubating a further 2.5 h, the bacterial suspension was
centrifuged, and the bacterial pellet was stored at 70°C for further
use.
DNA sequencing. The DNA sequence of opdB cloned into pET30b
was examined using the T7 promoter primer (5 TAA TAC GAC TCA
CTA TAG GG 3; Novagen) to confirm the expected plasmid construct.
Sequencing reactions were performed by using ABI PRISM BigDye
Terminator Cycle Sequencing Kits with fluorescent-labeled
dideoxynucleoside triphosphates (Applied Biosystems Inc., Foster
Fig 1. Strategy of cloning opdB into pET30b. The
opdB PCR product was TA cloned into pSTBlue-l.
The resulting plasmid pSY113 was digested with
NdeI and HindIII and cloned into pET30b digested
with the same set of restriction enzymes. The re-
sulting plasmid pSY115 was transformed into E.
coli BL21(DE3)/pLysS strain.
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City, CA, USA) and a primer, according to the manufacturer’s instruc-
tions. DNA sequences were resolved by using an ABI Prism 310
Genetic Analyzer (PE Applied Biosystems).
Enzymatic activity assays. Enzymatic activities of T. denticola and E.
coli strains containing T. denticola opdB were tested by assay of
hydrolysis of chromogenic substrates BApNA and succinyl-L-alanyl-
L-prolyl-L-phenylalanine-p-nitroanilide (SAAPFpNA; Sigma) as de-
scribed previously [3, 12]. Cultures were adjusted to an A600 of 0.25
and then diluted 1:8 in deionized water for assays. NOS broth diluted
1:8 in deionized water served as a negative control.
Results and Discussion
In designing an expression system for T. denticola opdB,
we faced two significant technical issues. Firstly, in our
experience recombinant expression of spirochete se-
creted proteins is often toxic to E. coli. Secondly, attain-
ing expression of enzymatically active recombinant pro-
teins can be problematic in any system. We utilized a
strategy in which the opdB coding sequence was first
cloned, with an engineered ATG start codon replacing
the native TTG start codon, in opposite orientation to a
vector-encoded promoter, yielding pSY113 (Fig. 1).
From this plasmid, the opdB coding sequence was sub-
cloned into the expression site in pET30b, such that the
opdB start codon was located optimally downstream of
the vector-encoded ribosome binding site and T7 RNA
polymerase promoter (pSY115, Fig. 1). The DNA se-
quence of opdB cloned into pET30b was confirmed by
sequencing (data not shown). After transfer of pSY115 to
the expression host BL21(DE3)/pLysS, opdB transcrip-
tion could be controlled by IPTG induction of expression
of T7 RNA polymerase in this strain.
Enzymatic activities in E. coli BL21(DE3)/pLysS
transformed with pSY115 (pET30b with opdB) are
shown in Fig. 2A. Induction of opdB expression resulted
in a high level of BApNA-hydrolyzing activity, equal
that of T. denticola ATCC 35405 cultures at the same
optical density. Enzyme activity in uninduced cultures
was barely detectable and was indistinguishable from
that of the host strain lacking pSY115. This observation
is consistent with the presence of a native opdB gene in
E. coli that is expressed at very low levels.
To confirm the specificity of the OpdB enzyme
activity expressed in E. coli, we also tested the ability of
induced cultures expressing the T. denticola opdB gene
to hydrolyze SAAPFpNA, a chromogenic substrate rec-
ognized by the T. denticola CTLP protease (dentilisin).
In contrast to the high level of activity in T. denticola,
there was no significant SAAPFpNA-degrading activity
in any of the E. coli strains with or without IPTG induc-
tion (Fig. 2B).
Though the BApNA hydrolyzing activity of
IPTG-induced E. coli BL21(DE3)/pLysS transformed
with pSY115 was as high as that of T. denticola ATCC
35405, expression of the OpdB protein in this vector
system was not very efficient. Coomassie Blue-stained
SDS-PAGE of IPTG-induced E. coli BL21(DE3)/
pLysS transformed with pSY115 did not show any
over-expressed protein band when compared with E.
coli BL21(DE3)/pLysS non-transformed with pSY115
(data not shown). This is consistent with our observa-
tion in T. denticola that, though there is a significant
level of OpdB enzyme activity, the OpdB protein is
Fig 2. Enzymatic activities of E. coli BL21(DE3)/pLysS transformed with pSY115 and T. denticola ATCC 35405. (A) Trypsin-like activity
measured by BApNA hydrolysis. (B) Chymotrypsin-like activity measured by SAAPFpNA hydrolysis. Vertical bars show standard deviations of
triplicate samples.
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not highly expressed compared with other membrane-
associated proteins [3].
In this study, we achieved recombinant expression
of the T. denticola ATCC 35405 BANA-peptidase gene
opdB in E. coli and demonstrated that the recombinant
strain produced the specific peptidase activity at levels
similar to that of T. denticola. Availability of a recom-
binant expression system that produces active OpdB
peptidase will facilitate characterization of the potential
role of this “BANA-peptidase” in periodontal disease
etiology.
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